Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer

View source ↗

Summary

This document reports the completion of an observational study evaluating Avastin (bevacizumab) in combination with paclitaxel as first-line therapy for HER2-ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED